Macquarie Group
INSM icon

Macquarie Group’s Insmed INSM Stock Holding History

Macquarie Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$554K Hold
5,193
– – ﹤0.01% 705
2026
Q1 		$849K Sell
5,193
-2,100
-29% -$323K 0.01% 653
2025
Q4 		$1.27M Sell
7,293
-642,554
-99% -$117M 0.01% 636
2025
Q3 		$93.6M Sell
649,847
-481,076
-43% -$58.9M 0.11% 247
2025
Q2 		$114M Sell
1,130,923
-1,231,182
-52% -$94.1M 0.14% 193
2025
Q1 		$180M Buy
2,362,105
+48,946
+2% +$3.74M 0.22% 96
2024
Q4 		$160M Buy
2,313,159
+27,238
+1% +$1.96M 0.19% 124
2024
Q3 		$167M Sell
2,285,921
-460,707
-17% -$34M 0.18% 137
2024
Q2 		$184M Sell
2,746,628
-1,152,876
-30% -$44.7M 0.21% 110
2024
Q1 		$106M Sell
3,899,504
-751,988
-16% -$21M 0.12% 231
2023
Q4 		$144M Sell
4,651,492
-2,280
-0% -$59.1K 0.17% 159
2023
Q3 		$118M Buy
4,653,772
+262,692
+6% +$6.01M 0.15% 186
2023
Q2 		$92.7M Buy
4,391,080
+338,716
+8% +$6.43M 0.11% 253
2023
Q1 		$69.1M Buy
4,052,364
+401,559
+11% +$7.8M 0.08% 321
2022
Q4 		$72.9M Buy
3,650,805
+92,881
+3% +$1.8M 0.09% 326
2022
Q3 		$76.7M Buy
3,557,924
+58,914
+2% +$1.41M 0.09% 293
2022
Q2 		$69M Buy
3,499,010
+123,905
+4% +$2.6M 0.08% 352
2022
Q1 		$79.3M Buy
3,375,105
+195,222
+6% +$4.54M 0.06% 369
2021
Q4 		$86.6M Sell
3,179,883
-195,383
-6% -$5.59M 0.07% 347
2021
Q3 		$93M Buy
3,375,266
+185,631
+6% +$4.87M 0.08% 323
2021
Q2 		$90.8M Buy
3,189,635
+2,927,018
+1,115% +$86.9M 0.07% 330
2021
Q1 		$8.94M Buy
262,617
+258,030
+5,625% +$9.86M 0.01% 742
2020
Q4 		$153K Hold
4,587
– – ﹤0.01% 1753
2020
Q3 		$147K Hold
4,587
– – ﹤0.01% 1684
2020
Q2 		$126K Buy
+4,587
New +$109K ﹤0.01% 1682
2018
Q3 		– Sell
-70,000
Closed -$1.66M – 2209
2018
Q2 		$1.66M Buy
+70,000
New +$1.8M ﹤0.01% 1043

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Macquarie Group's INSM Position: Q2 2026 in Review

Macquarie Group held its Insmed (INSM) position steady in Q2 2026 at 5,193 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Macquarie Group first reported a position in INSM in Q2 2018 and has held it in 26 quarters since. The position peaked at $184M in Q2 2024. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Macquarie Group held 5,193 shares of Insmed worth $554K as of Q2 2026.
  • Macquarie Group left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #705 holding.
  • Macquarie Group first reported a position in Insmed in Q2 2018 and has held it in 26 quarters since.
  • Macquarie Group's Insmed position peaked at $184M in Q2 2024.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.